Pediatric Biopharmaceutical Classification Systems (pBCS)

Pediatric Biopharmaceutical Classification Systems (pBCS)

The biopharmaceutical classification system, proposed in 1995 by Amidon in order to facilitate dissolution studies and to correlate their results with the bioavailability of a drug substance in vivo has been successfully used for almost 30 years in pharmaceutical sciences. It is also reflected in ma...

Full description

Bibliographic Details
Main Authors:	Justyna Srebro, Witold Brniak, Renata Jachowicz, Klaudia Syty, Katarzyna Tomaś
Format:	Article
Language:	Polish
Published:	Polish Pharmaceutical Society 2023-10-01
Series:	Farmacja Polska
Subjects:	bioequivalence biopharmaceutical classification system (bcs) in vitro/in vivo correlation pediatric drugs dissolution studies
Online Access:	https://www.ptfarm.pl/download/?file=File%2FFarmacja+Polska%2F2023%2F6%2F01_OG_Pediatryczne_systemy_pBCS_n.pdf

Similar Items

Exploring a Bioequivalence Failure for Silodosin Products Due to Disintegrant Excipients
by: Isabel González-Álvarez, et al.
Published: (2022-11-01)

Classification of WHO Essential Oral Medicines for Children Applying a Provisional Pediatric Biopharmaceutics Classification System
by: Jose-Manuel delMoral-Sanchez, et al.
Published: (2019-10-01)

Candesartan Cilexetil In Vitro–In Vivo Correlation: Predictive Dissolution as a Development Tool
by: Andrés Figueroa-Campos, et al.
Published: (2020-07-01)

ICH Guideline for Biopharmaceutics Classification System-Based Biowaiver (M9): Toward Harmonization in Latin American Countries
by: Claudia Miranda, et al.
Published: (2021-03-01)

Application of biopharmaceutical system of classification in development of new medicinal preparations
by: S. N. Gureyeva, et al.
Published: (2015-12-01)

Integrating In Vitro Biopharmaceutics into Physiologically Based Biopharmaceutic Model (PBBM) to Predict Food Effect of BCS IV Zwitterionic Drug (GSK3640254)
by: Konstantinos Stamatopoulos, et al.
Published: (2023-02-01)

Biopharmaceuticals. Official position of Russian Association of Endocrinologists
by: Editorial team Diabetes Mellitus
Published: (2013-09-01)

In Vivo Predictive Dissolution (IPD) for Carbamazepine Formulations: Additional Evidence Regarding a Biopredictive Dissolution Medium
by: Marival Bermejo, et al.
Published: (2020-06-01)

An In Vivo Predictive Dissolution Methodology (iPD Methodology) with a BCS Class IIb Drug Can Predict the In Vivo Bioequivalence Results: Etoricoxib Products
by: Isabel Gonzalez-Alvarez, et al.
Published: (2021-04-01)

Innovating on Inhaled Bioequivalence: A Critical Analysis of the Current Limitations, Potential Solutions and Stakeholders of the Process
by: Jonattan Gallegos-Catalán, et al.
Published: (2021-07-01)

Application of the Gastrointestinal Simulator (GIS) Coupled with In Silico Modeling to Measure the Impact of Coca-Cola<sup>®</sup> on the Luminal and Systemic Behavior of Loratadine (BCS Class 2b)
by: Bart Hens, et al.
Published: (2020-06-01)

An Overview on Dietary Polyphenols and Their Biopharmaceutical Classification System (BCS)
by: Francesca Truzzi, et al.
Published: (2021-05-01)

Development and Application of a Dissolution-Transfer-Partitioning System (DTPS) for Biopharmaceutical Drug Characterization
by: Christian Jede, et al.
Published: (2023-03-01)

Biopharmaceutics applications in drug development /
by: Krishna, Rajesh, et al.
Published: (2008)

New knowledge for omarigliptin tablets: dissolution assay -behavior in different media and biopharmaceutical classification
by: JULIANA EMANUELLI, et al.
Published: (2024-01-01)

Applied biopharmaceutics & pharmacokinetics /
by: Shargel, Leon, 1941-, et al.
Published: (2005)

Gliclazide: Biopharmaceutics Characteristics to Discuss the Biowaiver of Immediate and Extended Release Tablets
by: Bruna de Carvalho Mapa, et al.
Published: (2020-10-01)

Biopharmaceutics of Topical Ophthalmic Suspensions: Importance of Viscosity and Particle Size in Ocular Absorption of Indomethacin
by: Elisa Toropainen, et al.
Published: (2021-03-01)

An In Vitro–In Vivo Simulation Approach for the Prediction of Bioequivalence
by: Marilena Vlachou, et al.
Published: (2021-01-01)

The Role of Paracellular Transport in the Intestinal Absorption and Biopharmaceutical Characterization of Minoxidil
by: Milica Markovic, et al.
Published: (2022-06-01)

Solubility, Permeability, and Dissolution Rate of Naftidrofuryl Oxalate Based on BCS Criteria
by: Marta Kus-Slowinska, et al.
Published: (2020-12-01)

Biowaiver as a Bioequivalence Study Option
by: E. A. Volkova, et al.
Published: (2024-02-01)

A New Method for Studying the Kinetics of the Release of Poorly Soluble API from Solid Oral Dosage Forms on the Example of Quertin®
by: Nataliia V. Khanina, et al.
Published: (2023-11-01)

On Absorption Modeling and Food Effect Prediction of Rivaroxaban, a BCS II Drug Orally Administered as an Immediate-Release Tablet
by: Varun Kushwah, et al.
Published: (2021-02-01)

In vitro bioequivalence study of nine brands of artesunate tablets marketed in Nigeria
by: C.O. Esimone, et al.
Published: (2008-02-01)

Plasmid biopharmaceuticals : basics, applications, and manufacturing /
by: 520466 Prazeres, Duarte Miguel F.
Published: (c201)

Modern biopharmaceuticals : design, development and optimization /
by: Crick, Francis, 1916-2004, et al.
Published: (2005)

Goldstone and Higgs Hydrodynamics in the BCS–BEC Crossover
by: Luca Salasnich
Published: (2017-06-01)

Modern biopharmaceuticals : [compact disc] design, development and optimization /
by: Crick, Francis, 1916-2004, et al.
Published: (2005)

Status of the Indian biopharmaceutical industry and way forward to be a dominant global player
by: Prasanta Kumar Ghosh
Published: (2023-01-01)

In Vivo Predictive Dissolution and Biopharmaceutic-Based In Silico Model to Explain Bioequivalence Results of Valsartan, a Biopharmaceutics Classification System Class IV Drug
by: Isabel Gonzalez-Alvarez, et al.
Published: (2024-03-01)

BCS coupling in a 1D Luttinger liquid
by: R Eneias, et al.
Published: (2015-01-01)

Modeling in biopharmaceutics, pharmacokinetics, and pharmacodynamics : homogeneous and heterogeneous approaches /
by: Macheras, P. (Panos), et al.
Published: (2006)

Revisiting Supersaturation of a Biopharmaceutical Classification System IIB Drug: Evaluation via a Multi-Cup Dissolution Approach and Molecular Dynamic Simulation
by: Yanxiong Gan, et al.
Published: (2023-10-01)

Anomalous isotope effect in BCS superconductors with two boson modes
by: Gan Sun, et al.
Published: (2021-01-01)

Rabi Coupled Fermions in the BCS–BEC Crossover
by: Luca Dell’Anna, et al.
Published: (2022-10-01)

BCS Class IV Oral Drugs and Absorption Windows: Regional-Dependent Intestinal Permeability of Furosemide
by: Milica Markovic, et al.
Published: (2020-12-01)

QUALITY CONTROL MEASUREMENT AND IN VITRO BIOEQUIVALENCE OF VALSARTAN AND ATENOLOL TABLETS MARKETED IN UKRAINE
by: K. Y. Peleshok
Published: (2021-05-01)

The Dirac spectrum and the BEC-BCS crossover in QCD at nonzero isospin asymmetry
by: Bastian B. Brandt, et al.
Published: (2020-02-01)

Franz Cell Diffusion Testing and Quantitative Confocal Raman Spectroscopy: In Vitro-In Vivo Correlation
by: Fotis Iliopoulos, et al.
Published: (2020-09-01)